Life Sciences Client References

“Oxford Finance is one of the premier venture lending groups serving the life sciences community. Their continuity in the marketplace, as well as their professional and collaborative approach to transactions, makes them a logical go-to source for CFOs.”
John Schmid, Chief Financial Officer
Auspex Pharmaceuticals
“Cadence Pharmaceuticals and the entire senior management team at Oxford have developed a comfortable and deep working relationship over the years. Oxford has been very responsive to our financing requirements, and we can also count on them for timely execution.”
William LaRue, Senior Vice President,
Chief Financial Officer & Assistant Secretary
Cadence Pharmaceuticals
“A theme that ran throughout the loan negotiation process with Oxford was ‘flexibility’. Many firms claim to be willing to work with their clients; Oxford actually delivered on that promise. Their experienced team worked with us to ensure we ended up with the structure and terms we were seeking. The funds we received from Oxford provided the cash runway we needed at a time when the equity capital markets were unattractive to us.”
Sharon Barbari, Executive Vice President &
Chief Financial Officer
Cytokinetics
“Oxford has proven to be a great business partner. It takes a longer term view and is focused on helping to support the growth of our business. Oxford also understands the dynamics of the pharmaceutical industry quit well, which enhances the quality of our dialogue and has helped us find the right financing solution.”
Doug Saltel, President & Chief Executive Officer
Edgemont Pharmaceuticals
“Oxford is well known and highly regarded throughout the industry. The team was extremely knowledgeable, professional and responsive. They listened, took the time to understand our company’s business model and value drivers, and focused on what is important to IDEV Technologies.”
Bill Burke, Executive Vice President &
Chief Financial Officer
IDEV Technologies
“I have a long track record with Oxford, and have found them very easy to work with and competitively priced. They know the life sciences space, and have the flexibility and patience needed to support start-ups through the various stages of development.”
Richard Buchholz, Chief Financial Officer
Inspire Medical Systems
“Oxford has been in the life sciences field for a long time, and they have a thorough understanding of companies in this space. They understand business risks and that projections and final numbers may differ. The funds we received from Oxford enabled us to extend our runway at a minimal cost of capital dilution.”
Kevin Cousins, Vice President & Chief Financial Officer
Sequent Medical
“Oxford is a great choice for a lender. They delivered a financing structure that was strategically useful and tailored to our business plan. Oxford is a reliable and supportive partner that provided the financial strength we needed during our transition to a public company.”
Chris Peetz, Chief Financial Officer
Tobira Therapeutics
“Oxford delivers on their promises, and gets deals done with no surprises at the end. They value long-term relationships with their clients, and realize the importance of being upfront and following through from the term sheet to the final deal terms.”
Patty Allen, Chief Financial Officer
Zafgen

Providing Flexible and Creative Financial Solutions to Life Sciences and Healthcare Services Companies